Cite Filings / AKTS
Feed Companies Filings Check
Sign in

CIK 0002035832 · <br>Emerging growth company

Aktis Oncology, Inc.

Sign in to watch
Ticker
AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
852584233
Phone
978-237-4380
Business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
Filings Insiders Search text
All 70 Financials 10 Executive Compensation 7 Insider Trading 30 Beneficial Ownership Interest 5 Business Combinations 6 Public Offerings 8 Others 17
›
Filed in
  1. No filings match these filters. Clear filters
  2. 10-Q Report Quarterly Report 2026-11-12
  3. 8-K Event ● Results of operations 2026-11-12
  4. 10-Q Report Quarterly Report 2026-08-13
  5. 8-K Event ● Results of operations 2026-08-13
  6. 10-Q Report Quarterly Report 2026-05-11
  7. 8-K Event ● Results of operations 2026-05-11
  8. 8-K Event ● Executive or director change · Regulation FD disclosure 2026-04-16
  9. 8-K Event ● Results of operations 2026-03-30
  10. 10-K Report Annual Report 2026-03-30
  11. 8-K Event Bylaws or fiscal year change 2026-01-12

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…